参考文献/References:
[1].Wang J,Liu S,Heallen T,et al.The Hippo pathway in the heart: pivotal roles in development,disease,and regeneration[J]. Nat Rev Cardiol,2018,15(11):672-684.
[2].Galan JA,Avruch J.Mst1/Mst2 protein kinases: regulation and physiologic roles[J]. Biochemistry,2016,55(39):5507-5519.
[3].常文婧,王丽娜.Hippo通路在心脏发育、再生和疾病中的作用[J]. 心血管病学进展,2019,4(8):1115-1118.
[4].Meng Z,Qiu Y,Lin KC,et al. RAP2 mediates mechanoresponses of the Hippo pathway[J]. Nature,2018,560(7720):655-660.
[5].Yu FX,Zhao B,Guan KL. Hippo pathway in organ size control,tissue homeostasis,and cancer[J]. Cell,2015,163(4):811-828.
[6].Boggiano JC,Vanderzalm PJ,Fehon RG. Tao-1 phosphorylates Hippo/Mst kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway[J]. Dev Cell,2011,21(5):888-895.
[7].Rawat SJ,Chernoff J. Regulation of mammalian Ste20 (Mst) kinases[J]. Trends Biochem Sci,2015,40(3):149-156.
[8].Avruch J,Zhou D,Fitamant J,et al. Protein kinases of the Hippo pathway: regulation and substrates[J]. Semin Cell Dev Biol,2012,23(7):770-784.
[9].Pan B,Yang L,Wang J,et al. C-Abl tyrosine kinase mediates neurotoxic prion peptide-induced neuronal apoptosis via regulating mitochondrial homeostasis[J]. Mol Neurobiol,2014,49(2):1102-1116.
[10].Del Re DP,Matsuda T,Zhai P,et al. Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of Bcl-xL[J]. Mol Cell,2014,54(4):639-650.
[11].Hu J,Zhang L,Yang Y,et al. Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1[J]. J Pineal Res,2017,62(1):e12368.
[12].Nakamura M,Zhai P,Del Re DP,et al. Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury[J]. JCI Insight,2016,1(5):e86217.
[13].Maejima Y,Kyoi S,Zhai P,et al. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2[J]. Nat Med,2013,19(11):1478-1488.
[14].Nguyen MN,Ziemann M,Kiriazis H,et al. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling[J]. Am J Physiol Heart Circ Physiol,2019,316(1):H45-H60.
[15].Zhao WB,Lu Q,Nguyen MN,et al. Stimulation of β-adrenoceptors up-regulates cardiac expression of galectin-3 and BIM through the Hippo signalling pathway[J]. Br J Pharmacol,2019,176(14):2465-2481.
[16]. Nguyen MN ,Kiriazis H,Ruggiero D,et al. Spontaneous ventricular tachyarrhythmias in β2-adrenoceptor transgenic mice in relation to cardiac interstitial fibrosis[J]. Am J Physiol Heart Circ Physiol,2015,309(5):H946-H957.
[17].Xu Q,Dalic A,Fang L,et al. Myocardial oxidative stress contributes to transgenic β2-adrenoceptor activation-induced cardiomyopathy and heart failure[J]. Br J Pharmacol,2011,162(5):1012-1028.
[18].Lee YY,Moujalled D,Doerflinger M,et al. CREB-binding protein (CBP) regulates β-adrenoceptor (β-AR)-mediated apoptosis[J]. Cell Death Differ,2013,20(7):941-952.
[19].Peter PS,Brady JE,Yan L,et al. Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed β2-adrenergic receptor,but not β1-adrenergic receptor[J]. J Clin Invest,2007,117(5):1335-1343.
[20].Krishnamurthy P,Subramanian V,Singh M,et al. β1 integrins modulate β-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling[J]. Hypertension,2007,49(4):865-872.
[21]. Singh M ,Roginskaya M,Dalal S,et al. Extracellular ubiquitin inhibits β-AR-stimulated apoptosis in cardiac myocytes: role of GSK-3β and mitochondrial pathways[J]. Cardiovasc Res,2010,86(1):20-28.
[22].Dalal S,Foster CR,Das BC,et al. β-adrenergic receptor stimulation induces endoplasmic reticulum stress in adult cardiac myocytes: role in apoptosis[J]. Mol Cell Biochem,2012,364(1-2):59-70.
[23].Wang JD,Katz SG,Morgan EA,et al. Proapoptotic protein BIM as a novel prognostic marker in mantle cell lymphoma[J]. Hum Pathol,2019,93:54-64.
[24].Leach JP,Heallen T,Zhang M,et al. Hippo pathway deficiency reverses systolic heart failure after infarction[J]. Nature,2017,550(7675):260-264.
[25].Dalal S,Connelly B,Singh M,et al. NF2 signaling pathway plays a pro-apoptotic role in β-adrenergic receptor stimulated cardiac myocyte apoptosis[J]. PLoS One,2018,13(4):e0196626.
[26].Nguyen MN,Su Y,Vizi D,et al. Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure[J]. Sci Rep,2018,8(1):8213.
[27].Odashima M,Usui S,Takagi H,et al. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction[J]. Circ Res,2007,100(9):1344-1352.
[28].Sciarretta S,Zhai P,Maejima Y,et al. mTORC2 regulates cardiac response to stress by inhibiting Mst1[J]. Cell Rep,2015,11(1):125-136.
[29].Del Re DP,Matsuda T,Zhai P,et al. Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice[J]. J Clin Invest,2010,120(10):3555-3567.
[30].Hu J,Wang S,Xiong Z,et al. Exosomal Mst1 transfer from cardiac microvascular endothelial cells to cardiomyocytes deteriorates diabetic cardiomyopathy[J].Biochim Biophys Acta Mol Basis Dis,2018,1864(11):3639-3649.
[31].Chen SN,Gurha P,Lombardi R,et al. The Hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy[J]. Circ Res,2014,114(3):454-468.
[32].Lee GJ,Yan L,Vatner DE,et al. Mst1 inhibition rescues β1-adrenergic cardiomyopathy by reducing myocyte necrosis and non-myocyte apoptosis rather than myocyte apoptosis[J]. Basic Res Cardiol,2015,110(2):7.
[33].Hou N,Wen Y,Yuan X,et al. Activation of Yap1/Taz signaling in ischemic heart disease and dilated cardiomyopathy[J]. Exp Mol Pathol,2017,103(3):267-275.